Fulcrum Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,019
Closed -$2.7M 286
2025
Q1
$2.7M Sell
21,019
-1,054
-5% -$165K 0.52% 51
2024
Q4
$2.58M Sell
22,073
-1,047
-5% -$162K 12.06% 5
2024
Q3
$2.82M Sell
23,120
-620
-3% -$98.8K 6.46% 7
2024
Q2
$2.82M Buy
+23,740
New +$3.53M 8.77% 5

Other funds holding JNJ

Fulcrum Asset Management's JNJ Position: Q2 2026 in Review

Fulcrum Asset Management reduced its Johnson & Johnson (JNJ) stake by 9% in Q2 2026, selling an estimated $480K and leaving 20,815 shares worth $5.38M. The position accounts for 0.54% of the portfolio, ranked #43.

Fulcrum Asset Management first reported a position in JNJ in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.55M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Fulcrum Asset Management held 20,815 shares of Johnson & Johnson worth $5.38M as of Q2 2026.
  • Fulcrum Asset Management sold 2,061 Johnson & Johnson shares in Q2 2026, an estimated $480K.
  • Johnson & Johnson made up 0.54% of Fulcrum Asset Management's portfolio in Q2 2026, its #43 holding.
  • Fulcrum Asset Management first reported a position in Johnson & Johnson in Q2 2025 and has held it in 5 quarters since.
  • Fulcrum Asset Management's Johnson & Johnson position peaked at $5.55M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.